Scarica l'app Stockscreener
5.27
5.22%
-0.29
Precedente Chiudi:
$5.56
Aprire:
$5.6
Volume 24 ore:
113.30K
Relative Volume:
0.33
Capitalizzazione di mercato:
$16.44M
Reddito:
-
Utile/perdita netta:
$-68.80M
Rapporto P/E:
-4.5043
EPS:
-1.17
Flusso di cassa netto:
$-59.06M
1 W Prestazione:
-22.39%
1M Prestazione:
+1,248%
6M Prestazione:
+754.13%
1 anno Prestazione:
+485.62%
Intervallo 1D:
$5.1239
$6.0608
Intervallo di 1 settimana:
$5.1239
$7.0057
Portata 52W:
$0.257
$7.63
Passage Bio Inc Stock (PASG) Company Profile
Nome
Passage Bio Inc
Settore
Industria
Telefono
(267) 866-0312
Indirizzo
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Confronta PASG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
5.27 | 21.19M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-29 | Ripresa | Wedbush | Outperform |
| 2024-09-03 | Iniziato | Rodman & Renshaw | Buy |
| 2022-03-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-01-19 | Downgrade | Goldman | Buy → Neutral |
| 2021-07-01 | Iniziato | Raymond James | Outperform |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-03-04 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-02-04 | Iniziato | Guggenheim | Buy |
| 2021-01-25 | Iniziato | Wedbush | Outperform |
| 2021-01-04 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-12-11 | Iniziato | Citigroup | Neutral |
| 2020-08-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-06-25 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-25 | Iniziato | Chardan Capital Markets | Buy |
| 2020-03-24 | Iniziato | Cowen | Outperform |
| 2020-03-24 | Iniziato | Goldman | Buy |
| 2020-03-24 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Passage Bio Inc Borsa (PASG) Ultime notizie
What drives Passage Bio Inc. stock priceFree Stock Market Query - Autocar Professional
Is Passage Bio Inc. a good long term investmentTremendous return on equity - PrintWeekIndia
Passage Bio Inc. Stock Analysis and ForecastExceptional earning trajectories - Autocar Professional
What analysts say about Passage Bio Inc. stockUnprecedented market success - Autocar Professional
Gm1 Gangliosidosis Treatment Market Exclusive Report with - openPR.com
Passage Bio Approves 1-for-20 Reverse Stock Split to Maintain Nasdaq Compliance - MSN
Fierce Biotech Layoff Tracker 2025: Sarepta lays off 500 staffers; GSK trims R&D team - Fierce Biotech
How Passage Bio Inc. stock performs during market volatility5x Profit Potential - Newser
Why Passage Bio Inc. stock attracts strong analyst attention10x Return With Managed Risk - Newser
What makes Passage Bio Inc. stock price move sharplyFree Consultation - Newser
Passage Bio Announces Reverse Stock Split Effective July 14 - TipRanks
Passage Bio's Reverse Split: A Desperate Move or a Clever Play? - AInvest
Passage Bio Announces 1-for-20 Reverse Stock Split - citybiz
Passage Bio's Reverse Stock Split: A Necessary Gamble for Survival? - AInvest
Passage Bio announces 1-for-20 reverse stock split to regain compliance - Investing.com
Passage Bio Announces 1-for-20 Reverse Stock Split to Regain Nasdaq Compliance - Quiver Quantitative
Passage Bio Announces Major 1-for-20 Reverse Split, Shares Reduced from 62M to 3M - Stock Titan
Frontotemporal Dementia Market Sees Rise in Precision Medicine and Gene Therapy Approaches | DelveInsight - The Malaysian Reserve
Passage Bio (PASG) Announces Key Updates from PBFT02 Clinical Tr - GuruFocus
Breakthrough in Dementia Treatment: Gene Therapy Maintains 18-Month Efficacy with Lower Dose Success - Stock Titan
Annovis Bio Secures NYSE Approval to Regain Compliance with Listing Standards - MyChesCo
Passage Bio, Inc. (NASDAQ:PASG) Stake Cut by Two Sigma Investments LP - Defense World
Two Sigma Investments LP Makes New Investment in BioVie Inc. (NASDAQ:BIVI) - Defense World
10,923 Shares in Annovis Bio, Inc. (NYSE:ANVS) Bought by Two Sigma Investments LP - Defense World
American Battery Technology (NASDAQ:ABAT) Shares Purchased by Two Sigma Investments LP - Defense World
Millennium Management LLC Purchases Shares of 37,704 Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Squarepoint Ops LLC Has $36,000 Stake in Passage Bio, Inc. (NASDAQ:PASG) - Defense World
Semrush Holdings, Inc. (NASDAQ:SEMR) Shares Purchased by Bank of America Corp DE - Defense World
Lumina Gold (OTCMKTS:LMGDF) Trading Down 0.3% – Here’s Why - Defense World
Obsidian Energy (OTCMKTS:OBELF) Shares Up 2.7% – Here’s Why - Defense World
Carbios SAS (OTCMKTS:COOSF) Stock Price Up 5% – Here’s Why - Defense World
Suncrest Bank (OTCMKTS:SBKK) Shares Up 1% – Should You Buy? - Defense World
Color Star Technology (NASDAQ:CSCW) Trading 0.5% Higher – Here’s What Happened - Defense World
Inventiva (NASDAQ:IVA) Stock Price Up 0.8% – Here’s Why - Defense World
Fury Gold Mines (NYSEAMERICAN:FURY) Stock Price Down 3.2% – Here’s Why - Defense World
Nano Magic (OTCMKTS:NMGX) Shares Up 5% – What’s Next? - Defense World
Jane Street Group LLC Grows Holdings in Passage Bio, Inc. (NASDAQ:PASG) - Defense World
Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews
Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace
Passage Bio, Inc. (NASDAQ:PASG) Shares Purchased by Northern Trust Corp - Defense World
Two Sigma Investments LP Has $1.93 Million Stake in Haleon plc (NYSE:HLN) - Defense World
Passage Bio Adopts Key Proposals at Annual Meeting - TipRanks
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Position in Talkspace, Inc. (NASDAQ:TALK) - Defense World
D. E. Shaw & Co. Inc. Increases Holdings in 908 Devices Inc. (NASDAQ:MASS) - Defense World
VintaBio Showcases Breakthrough Gene Therapy Manufacturing Platform - MyChesCo
Metachromatic Leukodystrophy Pipeline 2025: Groundbreaking - openPR.com
GM1 Gangliosidosis Market: Epidemiology, Therapies, - openPR.com
Passage Bio Inc Azioni (PASG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):